交易信息汇总资金流向 截至2025年11月17日收盘，华北制药(600812)报收于6.15元，下跌1.28%，换手率1.13%，成交量19.34万 手，成交额1.19亿元。 当日关注点 华北制药股份有限公司于2025年5月16日发行2025年度第一期短期融资券，发行总额为人民币5.00亿 元，发行利率1.86%，期限180日，兑付日期为2025年11月15日。截至2025年11月17日，公司已完成本 期短期融资券的兑付工作，本息兑付金额共计人民币504,586,301.37元。 11月17日主力资金净流出590.71万元，占总成交额4.96%；游资资金净流入178.46万元，占总成交额 1.5%；散户资金净流入412.25万元，占总成交额3.46%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：11月17日主力资金净流出590.71万元，占总成交额4.96%。 来自公司公告汇总：华北制药已于2025年11月17日完成2025年度第一期短期融资券本息兑付，合 计支付504,586,301.37元。 公司公告汇总 ...

Core Viewpoint - Hongta Securities successfully completed the repayment of its first short-term financing bond for 2025, indicating strong financial management and liquidity position [1] Group 1: Stock Performance - As of September 17, 2025, Hongta Securities' stock closed at 9.04 yuan, up 0.33% from the previous trading day [1] - The stock opened at 8.99 yuan, reached a high of 9.14 yuan, and a low of 8.98 yuan, with a trading volume of 3.04 billion yuan and a turnover rate of 0.71% [1] Group 2: Financing Bond Details - The company issued its first short-term financing bond for 2025 on March 20, 2025, with a total issuance amount of 1 billion yuan and an interest rate of 2.02% for a term of 180 days [1] - The total repayment amount on September 17, 2025, was 1,009,961,643.84 yuan, which includes both principal and interest [1] - The board of directors confirmed the accuracy and completeness of the announcement, ensuring no misleading statements or omissions [1]

Group 1 - The company successfully issued the first phase of short-term financing bonds for 2025 on March 20, 2025, with a total issuance amount of 1 billion yuan and an interest rate of 2.02% [1] - The term of the bonds is 180 days, with a maturity date set for September 17, 2025 [1] - On the same day, the company completed the principal and interest repayment for this phase of short-term financing bonds, totaling 1,009,961,643.84 yuan [1]